Frontlight ResearchEarly access
Active, not recruitingPhase 4
Bicarbonate for the treatment of cardiac arrest
Key facts
- Who runs it
- Aarhus University Hospital
- Where
- Denmark21 sites in 1 countryChoose a country to see its sites
- Trial code
- Status
- Active, not recruiting
- Phase
- Phase 4
- People taking part
- 778 people, planned
- Started
- 6 Feb 2023
- Ended
- 31 Oct 2026
- Type of study
- Interventional
- Record updated
- 2 October 2024
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 9 criteriaShow less
Who can take part
- In-hospital cardiac arrest
- Age ≥ 18 years
- Received at least one dose of adrenaline during cardiopulmonary resuscitation
Who cannot take part
- Clearly documented “do-not-resuscitate” order prior to the cardiac arrest
- Prior enrollment in the trial
- Invasive mechanical circulatory support at the time of the cardiac arrest
- Known or suspected pregnancy at the time of the cardiac arrest
- Known objection by the patient to participate in the trial
- Clinical indication for bicarbonate administration
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
To determine whether sodium bicarbonate, as compared to placebo, when administered during in-hospital cardiac arrest, will increase return of spontaneous circulation.
Data and sources
- Registry record
- Listed on the EU's official list of trials (CTIS).How to verify a trial in the registry
- Official title
- Bicarbonate for In-Hospital Cardiac Arrest – A Randomized, Double-Blind, Placebo-Controlled Trial
- Record updated
- 2 October 2024